S
Stockadora
Back to Insider Trading View Full Company Profile

ROIV

HEALTHY

Roivant Sciences Ltd.

CIK: 0001635088

Strong Sell (90% confidence)

Last activity: 5 days ago

Financial Metrics

As of Mar 31, 2025 (10-K)

Revenue $29.05M
Net Income -$171.98M
Total Cash $4.89B
Total Debt $255.33M
Debt/Equity 0.05
Current Ratio 27.12

Insider Roster (11 total, 11 active)

Insider Buys Sells Net Value Holdings
Torti Frank
President and Vant Chair
 		0 3 -$82.04M
13,736,547 shares
$377.89M
MANCHESTER KEITH S
OTHER
 		0 10 -$71.72M
15,127,329 shares
$400.87M
Gold Daniel Allen
OTHER
 		0 10 -$71.72M
15,127,329 shares
$400.87M
QVT Financial LP
OTHER
 		0 10 -$71.72M
15,127,329 shares
$400.87M
Ramaswamy Vivek
TEN_PERCENT_OWNER
 		0 3 -$67.94M
34,132,463 shares
$752.62M
Sukhatme Mayukh
President & CIO
 		0 4 -$38.51M
19,148,664 shares
$506.87M
Gline Matthew
CEO
 		0 3 -$37.72M
18,616,406 shares
$403.60M
Venker Eric
President & Immunovant CEO
 		0 6 -$25.68M
1,647,546 shares
$46.53M
Pulik Richard
CFO
 		0 2 -$9.12M
386,144 shares
$8.67M
Fitzgerald Meghan
OTHER
 		0 1 -$1.92M
42,963 shares
$1.18M
Epperly Melissa B,
DIRECTOR
 		0 1 -$1.20M
15,804 shares
$453K

Recent Transactions

SELL Fitzgerald Meghan (OTHER)

70,000 shares @ $27.45

$1.92M

Mar 26, 2026

Conviction: | View SEC Filing →
SELL Venker Eric (President & Immunovant CEO)

200,000 shares @ $28.24

$5.65M

Mar 17, 2026

Conviction: | View SEC Filing →
SELL Epperly Melissa B, (DIRECTOR)

41,861 shares @ $28.68

$1.20M

Mar 16, 2026

Conviction: | View SEC Filing →
SELL Torti Frank (President and Vant Chair)

587,390 shares @ $27.51

$16.16M

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Torti Frank (President and Vant Chair)

1,012,610 shares @ $27.15

$27.49M

Feb 20, 2026

Conviction: | View SEC Filing →
SELL Torti Frank (President and Vant Chair)

1,400,000 shares @ $27.42

$38.39M

Feb 19, 2026

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

225,000 shares @ $26.50

$5.96M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

225,000 shares @ $26.50

$5.96M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

225,000 shares @ $26.50

$5.96M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL Venker Eric (President & Immunovant CEO)

200,000 shares @ $26.49

$5.30M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

150,784 shares @ $26.49

$3.99M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

150,784 shares @ $26.49

$3.99M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

150,784 shares @ $26.49

$3.99M

Feb 13, 2026

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

275,000 shares @ $26.76

$7.36M

Feb 12, 2026

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

275,000 shares @ $26.76

$7.36M

Feb 12, 2026

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

275,000 shares @ $26.76

$7.36M

Feb 12, 2026

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

150,000 shares @ $26.72

$4.01M

Feb 12, 2026

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

150,000 shares @ $26.72

$4.01M

Feb 12, 2026

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

150,000 shares @ $26.72

$4.01M

Feb 12, 2026

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

425,000 shares @ $26.67

$11.33M

Feb 11, 2026

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

425,000 shares @ $26.67

$11.33M

Feb 11, 2026

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

425,000 shares @ $26.67

$11.33M

Feb 11, 2026

Conviction: | View SEC Filing →
SELL Sukhatme Mayukh (President & CIO)

339,441 shares @ $26.47

$8.99M

Feb 9, 2026

Conviction: | View SEC Filing →
SELL Venker Eric (President & Immunovant CEO)

200,000 shares @ $21.92

$4.38M

Jan 12, 2026

Conviction: | View SEC Filing →
SELL Sukhatme Mayukh (President & CIO)

1,018,995 shares @ $21.71

$22.12M

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Sukhatme Mayukh (President & CIO)

311,873 shares @ $21.74

$6.78M

Dec 29, 2025

Conviction: | View SEC Filing →
SELL Venker Eric (President & Immunovant CEO)

75,000 shares @ $22.53

$1.69M

Dec 24, 2025

Conviction: | View SEC Filing →
SELL Pulik Richard (CFO)

260,000 shares @ $22.45

$5.84M

Dec 23, 2025

Conviction: | View SEC Filing →
SELL Venker Eric (President & Immunovant CEO)

200,000 shares @ $22.45

$4.49M

Dec 23, 2025

Conviction: | View SEC Filing →
SELL Pulik Richard (CFO)

146,731 shares @ $22.39

$3.29M

Dec 23, 2025

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

432,718 shares @ $23.05

$9.97M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

432,718 shares @ $23.05

$9.97M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

432,718 shares @ $23.05

$9.97M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

189,538 shares @ $23.17

$4.39M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

189,538 shares @ $23.17

$4.39M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

189,538 shares @ $23.17

$4.39M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

155,076 shares @ $23.02

$3.57M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

155,076 shares @ $23.02

$3.57M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

155,076 shares @ $23.02

$3.57M

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Sukhatme Mayukh (President & CIO)

26,831 shares @ $23.09

$620K

Dec 17, 2025

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

642,282 shares @ $23.08

$14.82M

Dec 16, 2025

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

642,282 shares @ $23.08

$14.82M

Dec 16, 2025

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

642,282 shares @ $23.08

$14.82M

Dec 16, 2025

Conviction: | View SEC Filing →
SELL MANCHESTER KEITH S (OTHER)

275,000 shares @ $22.93

$6.31M

Dec 16, 2025

Conviction: | View SEC Filing →
SELL QVT Financial LP (OTHER)

275,000 shares @ $22.93

$6.31M

Dec 16, 2025

Conviction: | View SEC Filing →
SELL Gold Daniel Allen (OTHER)

275,000 shares @ $22.93

$6.31M

Dec 16, 2025

Conviction: | View SEC Filing →
SELL Gline Matthew (CEO)

943,527 shares @ $21.68

$20.46M

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Gline Matthew (CEO)

566,116 shares @ $21.68

$12.27M

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Ramaswamy Vivek (TEN_PERCENT_OWNER)

353,745 shares @ $22.05

$7.80M

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Gline Matthew (CEO)

230,357 shares @ $21.68

$4.99M

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Ramaswamy Vivek (TEN_PERCENT_OWNER)

1,975,858 shares @ $21.96

$43.39M

Dec 12, 2025

Conviction: | View SEC Filing →
SELL Ramaswamy Vivek (TEN_PERCENT_OWNER)

774,142 shares @ $21.64

$16.75M

Dec 11, 2025

Conviction: | View SEC Filing →
SELL Venker Eric (President & Immunovant CEO)

200,000 shares @ $20.85

$4.17M

Dec 9, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.